HK1016070A1 - Composition for oral administration containing pyridazinone compounds - Google Patents

Composition for oral administration containing pyridazinone compounds

Info

Publication number
HK1016070A1
HK1016070A1 HK99101104A HK99101104A HK1016070A1 HK 1016070 A1 HK1016070 A1 HK 1016070A1 HK 99101104 A HK99101104 A HK 99101104A HK 99101104 A HK99101104 A HK 99101104A HK 1016070 A1 HK1016070 A1 HK 1016070A1
Authority
HK
Hong Kong
Prior art keywords
composition
oral administration
administration containing
pyridazinone compounds
containing pyridazinone
Prior art date
Application number
HK99101104A
Other languages
English (en)
Inventor
Toru Iwao
Tomoyo Seki
Nobuo Kondo
Yasuo Ueda
Original Assignee
Nissan Chemical Ind Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nissan Chemical Ind Ltd filed Critical Nissan Chemical Ind Ltd
Publication of HK1016070A1 publication Critical patent/HK1016070A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A61K31/501—Pyridazines; Hydrogenated pyridazines not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
HK99101104A 1997-01-31 1999-03-16 Composition for oral administration containing pyridazinone compounds HK1016070A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1911597 1997-01-31

Publications (1)

Publication Number Publication Date
HK1016070A1 true HK1016070A1 (en) 1999-10-29

Family

ID=11990489

Family Applications (1)

Application Number Title Priority Date Filing Date
HK99101104A HK1016070A1 (en) 1997-01-31 1999-03-16 Composition for oral administration containing pyridazinone compounds

Country Status (9)

Country Link
US (1) US5942249A (xx)
EP (1) EP0860169B1 (xx)
KR (1) KR100509170B1 (xx)
CN (1) CN1114408C (xx)
CA (1) CA2228078C (xx)
DE (1) DE69825193T2 (xx)
ES (1) ES2224296T3 (xx)
HK (1) HK1016070A1 (xx)
TW (1) TW482675B (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1163230C (zh) * 1998-12-07 2004-08-25 日产化学工业株式会社 勃起功能障碍治疗剂
ATE431136T1 (de) * 2000-09-22 2009-05-15 Dainippon Sumitomo Pharma Co Orale zubereitungen mit vorteilhaften zerfallseigenschaften
US20090117190A1 (en) * 2005-08-23 2009-05-07 Nissan Chemical Industries, Ltd. Sustained-release preparation
EP2329823A4 (en) * 2008-09-03 2013-04-03 Takeda Pharmaceutical METHOD FOR IMPROVING CAPACITY OF PREPARATION TO BE ABSORBED AND PREPARATION WHICH CAPACITY TO BE ABSORBED IS IMPROVED
WO2010074090A1 (ja) 2008-12-25 2010-07-01 日産化学工業株式会社 ピリダジン－３（２ｈ）－オン化合物塩酸塩の結晶及びその製造方法
JP5699339B2 (ja) * 2010-02-12 2015-04-08 日産化学工業株式会社 徐放性製剤
US9555115B2 (en) 2012-09-19 2017-01-31 Taiho Pharmaceutical Co., Ltd. Pharmaceutical composition for oral administration with improved dissolution and/or absorption

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02256668A (ja) * 1988-12-20 1990-10-17 Nissan Chem Ind Ltd ピリダジノン誘導体
US5167947A (en) * 1989-10-26 1992-12-01 Southwest Research Institute Enhancement of absorption of radioprotective drugs
US5364646A (en) * 1990-01-10 1994-11-15 Dr. Karl Thomae Gmbh Oral pharmaceutical forms of pimobendan
WO1991015205A1 (fr) * 1990-04-06 1991-10-17 Eisai Co., Ltd. Preparation buccale solide contenant un compose de catechol
CA2039742A1 (en) * 1990-04-23 1991-10-24 Andrew B. Dennis Tablet composition and method for problem pharmaceutical materials
JPH07107055B1 (xx) * 1990-04-25 1995-11-15
CA2061520C (en) * 1991-03-27 2003-04-22 Lawrence J. Daher Delivery system for enhanced onset and increased potency
CN1049892C (zh) * 1994-01-25 2000-03-01 日产化学工业株式会社 哒嗪酮衍生物及其盐,其制造方法,及抗血小板医药组合物
IL112695A (en) * 1994-02-22 1999-04-11 Green Cross Corp Pharmaceutical compositions containing pyridazinone derivatives

Also Published As

Publication number Publication date
US5942249A (en) 1999-08-24
CA2228078C (en) 2007-03-13
CN1114408C (zh) 2003-07-16
DE69825193T2 (de) 2005-08-11
CA2228078A1 (en) 1998-07-31
DE69825193D1 (de) 2004-09-02
CN1194139A (zh) 1998-09-30
EP0860169A2 (en) 1998-08-26
ES2224296T3 (es) 2005-03-01
EP0860169A3 (en) 1999-06-16
TW482675B (en) 2002-04-11
KR100509170B1 (ko) 2005-11-11
KR19980070938A (ko) 1998-10-26
EP0860169B1 (en) 2004-07-28

Similar Documents

Publication Publication Date Title
HK1017854A1 (en) Oral composition
PL329347A1 (en) Inandronate containing pharmaceutic agent for oral administration
ZA987552B (en) Pharmaceutical composition for combination of piperidino-alkanol-decongestant
ZA986889B (en) Controlled release pharmaceutical compositions containing tiagabine
PL334100A1 (en) Cyclosporin containing compositions for oral administration
IL111007A0 (en) Composition containing rapamycin for oral administration
PL315679A1 (en) Liquid compositions for oral administration containing paroxetin resinate
PL339461A1 (en) Orally administered compositions containing levosimendane
HUP0103924A3 (en) Oral pharmaceutical compositions containing buprenorphin
EP0978288A4 (en) DRUG COMPOSITION
PL319898A1 (en) Cyclosporines containing compositions for oral administration
IL123525A0 (en) Rapamycin formulations for oral administration
PL338922A1 (en) Oral compositions
AU6370299A (en) Pharmaceutical compositions containing tetrahydroisoquinoline compounds
IL133928A0 (en) Pharmaceutical composition containing peptichemio
ZA9710919B (en) Pharmaceutical compositions containing N-sulphony-lindole derivatives
HK1016070A1 (en) Composition for oral administration containing pyridazinone compounds
EP0953359A4 (en) PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION
HUP0003341A3 (en) Rapamycin formulations for oral administration
HUP9602024A3 (en) Pharmaceutical composition containing aminoacid for external use
HUP0003528A3 (en) Pharmaceutical compositions containing dihydropolyprenols
ZA974125B (en) Oral pharmaceutical compositions
SG63838A1 (en) Oral composition
HUP0101012A3 (en) Pharmaceutical composition for oral administration
DK0860169T3 (da) Præparater til oral administrering indeholdende pyridazinonforbindelser

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20120131